RJ
Randeep Jaikaria Singh
About Randeep Jaikaria Singh
Data last updated:
Randeep Jaikaria Singh is a Director at New India Biopharma Private Limited (since 2018). The company operates in Financial Services. New India Biopharma Private Limited reported revenue of ₹1.62 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 New India Biopharma Private Limited U51397DL2011PTC215424 | Director | 14 Dec 2018 | 2011 | ₹1.62 Cr (FY 2025) | Active |
Board colleagues of Randeep Jaikaria Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nergish Dadi Mistry | 03229912 | New India Biopharma Private Limited | Director |
| Rakesh Ahuja | 09144227 | New India Biopharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Randeep Jaikaria Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Randeep Jaikaria Singh
Randeep Jaikaria Singh currently holds 1 directorship: New India Biopharma Private Limited (Director, since 14 Dec 2018, revenue ₹1.62 Cr (FY 2025)).
Randeep Jaikaria Singh was first appointed on 14 Dec 2018 as Director at New India Biopharma Private Limited.
The current boards of Randeep Jaikaria Singh's companies include Nergish Dadi Mistry (New India Biopharma Private Limited), Rakesh Ahuja (New India Biopharma Private Limited).